Loading
A phase 2 trial of Endoscopic resection in Oesophageal squamous cell carcinoma, run by Chinese Academy of Medical Sciences, with a status the registry has not verified recently.
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma is a phase 2 interventional study registered as NCT04275986 by Chinese Academy of Medical Sciences, with 56 participants planned, started 2020-01-20 and due to reach its primary completion in 2024-01. Interventions recorded: Intensity modulated radiotherapy (IMRT), Chemotherapy. Conditions recorded: Esophageal Squamous Cell Carcinoma.
Linked to the technology Endoscopic resection because the registry's title names it ("endoscopic resection") and Oesophageal squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
Shares Endoscopic resection (EMR / ESD), Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.
Shares Oesophageal squamous cell carcinoma and the tag pipeline.